openPR Logo
Press release

Bladder Cancer Market 2019 Analysis - Research Covers Top 10 Players as AstraZeneca Plc., Bristol-Myers Squibb Company, Celgene Corporation, GlaxoSmithKline Plc., Novartis International AG, Sanofi S.A., Accord Healthcare Etc

02-08-2019 10:22 AM CET | Associations & Organizations

Press release from: Market Research Future

Bladder Cancer Market

Bladder Cancer Market

The Global Bladder Cancer Market is expected to grow at a CAGR of Approximately 12.5% During the Forecast Period 2017–2023.

Bladder Cancer Market - Segmentation                  

By type, the global bladder cancer market has been segmented into transitional cell bladder cancer, invasive bladder cancer, superficial bladder cancer, squamous cell bladder cancer, adenocarcinoma, and others.

By treatment, the bladder cancer market is segmented into chemotherapy, immunotherapy, radiation therapy, surgery, and others.

By diagnosis, the global bladder cancer market has been segmented into urine lab tests, cystoscopy, biopsy, imaging tests, and others.

By end-user, the bladder cancer market is segmented into hospitals, clinics, cancer care centers, and others.

Exclusive Sample Copy @

Bladder Cancer Market - Competitive Dashboard

Some of the key players profiled in the report are Bristol-Myers Squibb Company (U.S.), Celgene Corporation (U.S.), AstraZeneca Plc. (U.K.), Eli Lilly and Company (U.S.), GlaxoSmithKline Plc. (U.S.), Novartis International AG (Switzerland), F. Hoffmann-La Roche AG (Switzerland), Pfizer Inc. (U.S.), Sanofi S.A. (France), Accord Healthcare (U.S.), Bedford Lab (U.S.), and Merck & Co. Inc. (U.S.).

Bladder Cancer Market - Insights   

Market Research Future (MRFR)’s recent study projects that the global bladder cancer market is set to expand saliently at a robust CAGR of 12.5% during the forecast period 2017 to 2023. The rising burden of bladder cancer coupled with technological advancements in the healthcare sector is anticipated fuel growth in the market.

The risk factors related to bladder cancer such as continuous exposure to radiation, chronic bladder infection, tobacco consumption, and excessive smoking are expected to fuel demand in the bladder cancer market. Other factors responsible for favoring the bladder cancer market growth are drug innovations, the rise in aging population, government initiatives, advanced health care services, increasing healthcare expenditure, etc.

The restraints to the market growth that are expected to hold the revenue generation over the next couple of years include asymptomatic nature of the disease, drug patent expirations, high costs of therapies, the rise in the use of generic drugs, etc.

Industry Developments  

In August 2018, Agilent Technologies, American public research, development, and manufacturing company, announced that it has received FDA approval for its test, PD-L1 IHC 22C3 pharmDx assay, which can be used for the identification of bladder cancer patients who might benefit from Keytruda.

In September 2018, it has been announced that BREATHALYSERS, breath test for cancer detection, will be available in GP surgeries within a few years. Initially, it will be used for detecting lung, bowel, and esophagus and stomach cancer and will be expanded to the bladder, pancreas, and prostate later on.

Browse Complete 85 Pages Premium Research Report Enabled with 80 Respective Tables and Figures at

Bladder Cancer Market - Regional Analysis  

By region, the global bladder cancer market has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas is expected to retain a dominant position globally throughout the forecast period. The factors favoring the market growth in the region include the rising burden of bladder cancer, innovations in healthcare solutions, availability of advanced healthcare infrastructure, etc. Although the U.S. is estimated to grow at a relatively slower pace, it is still likely to account for a dominant share of the regional market.

Europe is expected to remain a highly lucrative market over the assessment period. The factors encouraging the market growth in the region are the availability of better healthcare solutions coupled with a rise in bladder cancer cases. Asia Pacific is anticipated to register a high growth rate owing to increasing awareness about bladder diseases and developments in treatments.

Major TOC for Bladder Cancer Market Research Report - Forecast to 2023:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

TOC Continued……!

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312


This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bladder Cancer Market 2019 Analysis - Research Covers Top 10 Players as AstraZeneca Plc., Bristol-Myers Squibb Company, Celgene Corporation, GlaxoSmithKline Plc., Novartis International AG, Sanofi S.A., Accord Healthcare Etc here

News-ID: 1571959 • Views: 1084

More Releases from Market Research Future

Clinical Trial Management System Market Demand, Industry Share, Size, Applicatio …
Clinical Trial Management System Market Analysis by Type (Enterprise Clinical Trial Management System), Delivery Model (Licensed Enterprise), Component (Service) and End-User (Medical Device Manufacturers), and Regional Competitive Share, Size and Trends, 2018-2023 Market Overview Clinical Trial Management System Market is mostly a software system which helps to plan, prepare, and manage a large amount of clinical trials data that is produced by biotechnological and pharmaceutical companies. Drug research has gained momentum in
Reusable Satellite Launch Vehicle (RSLV) Market 2019-2023 | Report Information b …
Global Reusable Satellite Launch Vehicle Market Report Information by Configuration (Single Stage, Multiple Stage), by Type (Partially Reusable, Fully Reusable), Vehicle Weight (Up to 4,000lbs, 4000-9000lbs, Over 9000lbs), & by Region - Forecast Till 2023 The Reusable satellite launch vehicle market is estimated to witness a CAGR of more than 12% during the forecast period from 2018 to 2023. The key players in the reusable satellite launch vehicle market are Airbus S.A.S
Bakery Enzymes Market Global Research Report and Top Key Players: AB Enzymes Gmb …
Market Overview The increasing demand for bakery products in the food and beverage industry including, bread, cookies, and pastries are raising the demand for bakery enzymes at a global level. Enzymes are an important ingredient used in most bakery products. There are two scenarios regarding the use of enzymes, either the enzymes are used to convert the raw material into the main product, or the enzymes are used as additives to
Commercial Airport Lighting Market 2019-2023 | Worldwide Overview By Technology, …
Global Commercial Airport Lighting Market Research Report: Information by Technology (LED, Non-LED), by Application (Airside Lighting, Terminal Lighting, Landside Lighting), and by Region — Forecast till 2023 Honeywell International Inc., (US), ADB SAFEGATE (US), ABB (Switzerland), vosla GmBH (Germany), Avlite (Australia), Carmanah (Canada), Eaton (Ireland), atg airports limited (UK), Avionics Group (US), and HELLA GmBH & Co. KGaA (Germany) are some of the prominent players profiled in MRFR Analysis and are

All 5 Releases

More Releases for Bladder

Bladder Cancer Therapeutics Market : How the Bladder Cancer Therapeutics Market …
As per stats released by the World Cancer Research Fund International, around 430,000 new cases of bladder cancer were diagnosed in 2012, with bladder cancer being the ninth-most common cancer. The bladder holds urine before it leaves the body during urination. The disease in which cancerous cells form in the tissues of the bladder is known as bladder cancer. Download Free PDF Brochure Of This Research Report @ There
Global Bladder Scanners Sales Market Report 2018
This report studies the global Bladder Scanners market status and forecast, categorizes the global Bladder Scanners market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). A bladder scanner is a medical device that utilizes ultrasound to noninvasively measure the amount of
Bladder Cance rMarket entry and expansion strategies
MarketResearchReports.Biz adds “Global Bladder Cancer Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Bladder Cancer and the growth estimates for the forecasted period. Bladder cancer is a rapidly evolving field in which new developments are constantly influencing the market landscape. The Dynamic Market Forecast is designed to help clients stay abreast of the latest news in the bladder
Bladder Cancer Pharmaceutical and Healthcare Analysis Information
Summary Bladder cancer occurs in tissues of the urinary bladder. Symptoms include blood or blood clots in the urine, frequent urination, lower back pain on one side of the body and burning during urination. Risk factors for bladder cancer include smoking, exposure to substances such as rubber, certain dyes and textiles, paint, and hairdressing supplies, diet rich in fried meats and fat, old age, sex and color, certain parasitic infections. Treatment
Bladder Scanners Market Research Report 2011-2023
Browse full table of contents and data tables at : Summary A bladder scanner is a medical device that utilizes ultrasound to noninvasively measure the amount of urine in the bladder or to determine how much urine remains in the bladder after urination as a way to measure residual levels. Request a sample copy at : The type of scanner is a niche ultrasound system that provides fast
04-28-2017 | Health & Medicine
Bladder Cancer Market Research Report : Forecast 2025
Bladder cancer is a urologic malignancy occurring in the tissues of the urinary bladder. It is characterized by the uncontrolled, rapid growth of cells arising from the epithelial lining and can be proliferating to the muscular wall of urinary bladder. The bladder or urinary bladder is a hollow organ located in the pelvis (lower abdomen) which stores the urine drained from kidney. It is connected to the kidney by ureters,